The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
In the two decades that have elapsed since the molecular chaperone Hsp90 2The abbreviations used are:Hspheat shock proteinE3ubiquitin-protein isopeptide ligaseCHIPC terminus of Hsc70-interacting proteinLBDligand binding domainGRglucocorticoid receptorHopHsp-organizing proteinTPRtetratricopeptide repeatHDAChistone deacetylasenNOSneuronal nitric-oxide synthase. 2The abbreviations used are:Hspheat shock proteinE3ubiquitin-protein isopeptide ligaseCHIPC terminus of Hsc70-interacting proteinLBDligand binding domainGRglucocorticoid receptorHopHsp-organizing proteinTPRtetratricopeptide repeatHDAChistone deacetylasenNOSneuronal nitric-oxide synthase. was shown to regulate the function of steroid receptors (1Pratt W.B. Toft D.O. Endocr. Rev. 1997; 18: 306-360Crossref PubMed Scopus (1529) Google Scholar), >200 signaling proteins have been found to be regulated by Hsp90 (2Picard D. CMLS Cell. Mol. Life Sci. 2002; 59: 1640-1648Crossref PubMed Scopus (654) Google Scholar). These Hsp90 “client” proteins form complexes containing Hsp90 and Hsp70 that are assembled by a multichaperone machinery (3Pratt W.B. Toft D.O. Exp. Biol. Med. 2003; 222: 111-133Crossref Scopus (1252) Google Scholar), with Hsp90 regulating both signaling protein function and turnover. Degradation of these Hsp90-regulated signaling proteins occurs via the ubiquitin-proteasome pathway (4Glickman M.H. Ciechanover A. Physiol. Rev. 2002; 82: 373-428Crossref PubMed Scopus (3323) Google Scholar), which in this case is initiated by Hsp70-dependent E3 ligases, such as CHIP and parkin (5Cyr D.M. Hohfeld J. Patterson C. Trends Biochem. Sci. 2002; 27: 368-375Abstract Full Text Full Text PDF PubMed Scopus (288) Google Scholar). Formation of a complex with Hsp90 stabilizes the client signaling protein, and treatment with a specific inhibitor of Hsp90, such as geldanamycin, triggers its rapid degradation (6Neckers L. Schulte T.W. Mimnaugh E. Investig. New Drugs. 1999; 17: 361-373Crossref PubMed Scopus (286) Google Scholar). Because many of the Hsp90-regulated signaling proteins are involved in cancer cell growth, Hsp90 inhibitors have emerged as a promising new class of anticancer drugs (7Sharp S. Workman P. Adv. Cancer Res. 2006; 95: 323-347Crossref PubMed Scopus (274) Google Scholar). heat shock protein ubiquitin-protein isopeptide ligase C terminus of Hsc70-interacting protein ligand binding domain glucocorticoid receptor Hsp-organizing protein tetratricopeptide repeat histone deacetylase neuronal nitric-oxide synthase. heat shock protein ubiquitin-protein isopeptide ligase C terminus of Hsc70-interacting protein ligand binding domain glucocorticoid receptor Hsp-organizing protein tetratricopeptide repeat histone deacetylase neuronal nitric-oxide synthase. In this Minireview, we provide a mechanistic basis for understanding how the abundant and ubiquitous chaperones Hsp90 and Hsp70 function together as essential components of the Hsp90 chaperone machinery to regulate signaling protein function and turnover. Like other chaperones, Hsp90 alone has been shown in vitro to assist the refolding of partially unfolded proteins to a properly folded, active conformation. However, Hsp90 is not required for de novo protein folding (8Nathan D.F. Vos M.H. Lindquist S. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 12949-12956Crossref PubMed Scopus (311) Google Scholar), and it is likely that in cells Hsp90 acts only in concert with Hsp70 in the multichaperone machinery. In contrast to the in vitro experiments on unfolded substrates, this Hsp90 machinery acts on proteins that are in their native conformations to assist the opening of ligand binding clefts. These clefts are hydrophobic clefts that must open to allow access of ligands, such as steroids, ATP, and heme, to their binding sites within the protein's interior. In the absence of the chaperone machinery, ligand binding clefts are dynamic, shifting to varying extents between closed and open states. When clefts open, hydrophobic residues of the protein's interior are exposed to solvent, and continued opening may progress to protein unfolding. Therefore, the extent to which the ligand binding cleft is open determines ligand access and thus protein function, but clefts are inherent sites of conformational instability. The chaperone machinery assists cleft opening, and Hsp90 binding stabilizes the open state of the cleft, preventing further unfolding and Hsp70-dependent ubiquitination. The Hsp90 client proteins are assembled into complexes with the chaperone that are stable enough to be isolated and analyzed biochemically. Although we will refer to these as “stable” Hsp90 complexes, they are constantly undergoing cycles of assembly and disassembly in the cytoplasm and nucleoplasm (3Pratt W.B. Toft D.O. Exp. Biol. Med. 2003; 222: 111-133Crossref Scopus (1252) Google Scholar). We will refer to this client protein cycling with Hsp90 as stable cycling. As we will show, a variety of manipulations, including mutations of the LBD or liga
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153
Self-citationLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787
Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement
Pratt, W. B., Galigniana, M. D., Harrell, J. M., & DeFranco, D. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.02.004 · Cited by 285
Self-citationMorishima, Y., Murphy, P. J. M., Li, D.-P., Sanchez, E. R., & Pratt, W. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000434200 · Cited by 166
Self-citationMorishima, Y., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R., Jenkins, G. J., Osawa, Y., Sunahara, R. K., & Pratt, W. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309814200 · Cited by 97
Self-citation
Cited by
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Taipale, M., Krykbaeva, I., Koeva, M., Kayatekin, C., Westover, K. D., Karras, G. I., & Lindquist, S. (2012) · Cell · doi:10.1016/j.cell.2012.06.047 · Cited by 879
Kirschke, E., Goswami, D., Southworth, D., Griffin, P. R., & Agard, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.04.038 · Cited by 399
Crosstalk between Hsp90 and Hsp70 Chaperones and Heat Stress Transcription Factors in Tomato
Hahn, A., Bublak, D., Schleiff, E., & Scharf, K.-D. (2011) · The Plant Cell · doi:10.1105/tpc.110.076018 · Cited by 396
In Vitro Assembly of Plant RNA-Induced Silencing Complexes Facilitated by Molecular Chaperone HSP90
Iki, T., Yoshikawa, M., Nishikiori, M., Jaudal, M. C., Matsumoto-Yokoyama, E., Mitsuhara, I., Meshi, T., & Ishikawa, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.014 · Cited by 325
Metadata
- Authors
- Pratt, W. B., Morishima, Y., & Osawa, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 283
- Issue
- 34
- Pages
- 22885-22889
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2041875984
- Cited by
- 151
- References
- 8
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts. https://app.cochat.ai/papers/10.1074/jbc.r800023200
- The paper
- Pratt, W. B., Morishima, Y., & Osawa, Y. (2008). The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r800023200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.